Annie T. Packard, M.D.

  1. Bihun R, Trinidad MC, Packard AT. Impact of Universal Vasa Previa Screening With Color Doppler During the OB Ultrasound Anatomy Scan. J Ultrasound Med. 2024 Mar; 43 (3):479-487 Epub 2023 Nov 27
    View PubMed
  2. Duncan ZN, Summerlin D, West JT, Packard AT, Morgan DE, Galgano SJ. PET/MRI for evaluation of patients with pancreatic cancer. Abdom Radiol (NY). 2023 Dec; 48 (12):3601-3609 Epub 2023 May 16
    View PubMed
  3. Bartlett DJ, Takahashi H, Bach CR, Lunn B, Thorpe MP, Broski SM, Packard AT, Fletcher JG, Navin PJ. Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvis. Abdom Radiol (NY). 2023 Dec; 48 (12):3624-3633 Epub 2023 May 05
    View PubMed
  4. Smith KA, Parvinian A, Ainsworth AJ, Shenoy CC, Packard AT. Normal and Abnormal Appearances of the Ovaries during Assisted Reproduction: Multimodality Imaging Review. Radiographics. 2023 Nov; 43 (11):e230089
    View PubMed
  5. Dunlay M, Gu C, Adamo D, Welch B, Packard A, Atwell T. Case series: The use of spermatic cord block in maximising patient comfort during ultrasound-guided percutaneous core-needle biopsy of the testicle. Australas J Ultrasound Med. 2023 Nov; 26(4):267-271. Epub 2023 Aug 07.
    View PubMed
  6. Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoglu K, Pandey MK, Packard AT, Halfdanarson TR, Hruska CB, Johnson GB, Kendi AT. A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements. Radiol Imaging Cancer. 2023 Jul; 5 (4):e220157
    View PubMed
  7. Larish A, Horst K, Brunton J, Schenone M, Branda M, Mehta R, Packard A, VanBuren W, Norgan A, Shahi M, Missert A, Pompeian R, Greenwood J, Theiler R. Focal-occult placenta accreta: a clandestine source of maternal morbidity. Am J Obstet Gynecol MFM. 2023 Jun; 5 (6):100924 Epub 2023 Mar 18
    View PubMed
  8. Pitot MA, Gu CN, Adamo DA, Kurup AN, Schmitz JJ, Packard AT. Safety and accuracy of aortic and periaortic CT-guided percutaneous core needle biopsy. Abdom Radiol (NY). 2023 Jun; 48 (6):2148-2156 Epub 2023 Mar 20
    View PubMed
  9. Kapplinger JD, Lima LMF, Packard AT, Nathan MA, Young JR, Stish BJ, Hough DM. Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by 11C-Choline PET in Patients With Prostate Cancer. AJR Am J Roentgenol. 2023 May; 220(5):718-725. Epub 2022 Dec 07.
    View PubMed
  10. Young JR, Mugu VK, Johnson GB, Ehman EC, Packard AT, Homb AC, Nathan MA, Thanarajasingam G, Kemp BJ. Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma. Medicine (Baltimore). 2023 Feb 10; 102 (6):e32665
    View PubMed
  11. Israel O, Nakajo M, Nunes RF, Packard AT. The Global Reading Room: Nuclear Medicine Imaging of a Diabetic Foot Ulcer. AJR Am J Roentgenol. 2022 Oct; 219 (4):681-682 Epub 2022 Jan 05
    View PubMed
  12. Broski SM, Johnson DR, Packard AT, Hunt CH. (18)F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors. PET Clin. 2022 Apr; 17 (2):249-263 Epub 2022 Feb 26
    View PubMed
  13. Patra A, Khasawneh H, Suman G, Nathan MA, Packard AT, Johnson GB, Goenka AH. Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer: (11)C-Choline PET/CT With Multimodality Correlation. AJR Am J Roentgenol. 2022 Jan; 218 (1):141-150 Epub 2021 Aug 04
    View PubMed
  14. Panda A, Sharma A, Dundar A, Packard A, Aase L, Kotsenas A, Kendi AT. Twitter Use by Academic Nuclear Medicine Programs: Pilot Content Analysis Study. JMIR Form Res. 2021 Nov 08; 5(11):e24448.
    View PubMed
  15. Wee CE, Dundar A, Eiring RA, Badawy M, Hobday TJ, Kendi AT, Packard AT, Halfdanarson TR. Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy. J Nucl Med 2021 Sep 1; 62 (9):1320 Epub 2021 Mar 19
    View PubMed
  16. Garg I, Nathan MA, Packard AT, Kwon ED, Larson NB, Lowe V, Davis BJ, Haloi R, Mahon ML, Goenka AH. (11)C-choline positron emission tomography/computed tomography for detection of disease relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen View PubMed
  17. Burkett BJ, Dundar A, Young JR, Packard AT, Johnson GB, Halfdanarson TR, Eiring RA, Gansen DN, Patton CM, Kendi AT. How We Do It: A Multidisciplinary Approach to (177)Lu DOTATATE Peptide Receptor Radionuclide Therapy. Radiology. 2021 Feb; 298 (2):261-274 Epub 2020 Nov 24
    View PubMed
  18. Frota Lima LM, Packard AT, Broski SM. Epithelioid hemangioendothelioma: evaluation by (18)F-FDG PET/CT. Am J Nucl Med Mol Imaging. 2021; 11 (2):77-86 Epub 2021 Apr 15
    View PubMed
  19. Clark MS, Packard AT, Johnson DR, Johnson GB. Pitfalls of a Mixed Metabolic Response at PET/CT. Radiographics. 2019 Sep-Oct; 39 (5):1461-1475 Epub 2019 Aug 09
    View PubMed
  20. Kendi AT, Halfdanarson TR, Packard A, Dundar A, Subramaniam RM. Therapy With (177)Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors. AJR Am J Roentgenol. 2019 Aug; 213 (2):309-317 Epub 2019 Apr 30
    View PubMed
  21. Stone JJ, Adamo DA, Khan DZ, Packard AT, Broski SM, Nathan MA, Howe BM, Spinner RJ. Multimodal Imaging Aids in the Diagnosis of Perineural Spread of Prostate Cancer. World Neurosurg. 2019 Feb; 122:e235-e240 Epub 2018 Oct 09
    View PubMed
  22. Welch BT, Packard AT, Atwell TD, Johnson GB, Lowe VJ, Karnes RJ, Mynderse LA, Gunderson TM, Park SS, Stish BJ, Evans JD, Kwon ED, Davis BJ, Nathan MA. Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):79-89 Epub 2018 Sept 05
    View PubMed
  23. Hendrickson AC, Schmitz JJ, Kurup AN, Eiken PW, Potretzke TA, Viers BR, McMenomy BP, Packard AT, Moynagh MR, Welch BT. Percutaneous ureteral biopsy: safety and diagnostic yield. Abdom Radiol (NY). 2019 Jan; 44 (1):333-336
    View PubMed
  24. Brown DL, Packard A, Maturen KE, Deshmukh SP, Dudiak KM, Henrichsen TL, Meyer BJ, Poder L, Sadowski EA, Shipp TD, Simpson L, Weber TM, Zelop CM, Glanc P, Expert Panel on Women's Imaging:. ACR Appropriateness Criteria((R)) First Trimester Vaginal Bleeding. J Am Coll Radiol. 2018 May; 15 (5S):S69-S77
    View PubMed
  25. Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Pract Radiat Oncol. 2017 Nov - Dec; 7 (6):e531-e541 Epub 2017 Apr 19
    View PubMed
  26. Xue Z, Wu F, Pierson KE, Mara KC, Yang P, Roden AC, Packard AT, Blackmon S. Survival in Surgical and Nonsurgical Patients With Superior Sulcus Tumors. Ann Thorac Surg. 2017 Sep; 104 (3):988-997 Epub 2017 June 23
    View PubMed
  27. Packard AT, Broski SM, Callstrom MR, Atwell TD, Schmit GD, Schmitz JJ, Morris JM, Hunt CH, Kurup AN. Utility of PET/CT After Cryoablation for Early Identification of Local Tumor Progression in Osseous Metastatic Disease. AJR Am J Roentgenol. 2017 Jun; 208 (6):1342-1351 Epub 2017 Mar 23
    View PubMed
  28. Youland RS, Packard AT, Blanchard MJ, Arnett AL, Wiseman GA, Kottschade LA, Dronca RS, Markovic SN, Olivier KR, Park SS. 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):204-210 Epub 2017 Feb 24
    View PubMed
  29. Arnett AL, Packard AT, Garces YI, Merrell KW. P1.21: Novel PET Parameters as Predictors of Pathologic Response in Patients With Stage IIIA(N2) NSCLC Receiving Trimodality Therapy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct; 11: (10S)S194-S195.
    View PubMed
  30. Warters RL, Packard AT, Kramer GF, Gaffney DK, Moos PJ. Differential gene expression in primary human skin keratinocytes and fibroblasts in response to ionizing radiation. Radiat Res. 2009 Jul; 172: (1)82-95.
    View PubMed